About us

Edward J. Ludwig

Chairman

Mr. Ludwig is lead independent director for the board of directors at Boston Scientific, director of CVS, and chair of the CVS board finance committee.

He formerly served as chairman of the board, president, and CEO of BD (Becton, Dickinson and Company); as director and lead independent director of the Aetna insurance company; as chair of the Finance, Innovation & Technology Committee at Xylem, Inc.; and as chairman of the board at AdvaMed. He also served as a senior auditor with Coopers and Lybrand (now PwC), and as a financial and strategic analyst at Kidde, Inc.

Mr. Ludwig is a founding board member of The Center for Higher Ambition Leadership (CHL), and a past chair of the Health Advisory Board for the Johns Hopkins Bloomberg School of Public Health. He was a member of the board of trustees at the College of the Holy Cross and of the Columbia Business School board of overseers, and a trustee of the Hackensack University Medical Center Network Board of Trustees.

Mr. Ludwig graduated from The College of the Holy Cross with a BA in economics and accounting, and received his MBA in finance from Columbia University.

Meir Hader

Director

Mr. Hader has over 30 years of experience in Commercial & Investment Banking, Mergers & Acquisitions, IPO’s & Secondaries, Management and Consulting, and has executed over 100 public & private equity placements. Previously, Mr. Hader was the president & CEO of YLR Capital Markets, underwriting & investments for 10 years. He was also the President & CEO of Orama Ltd., (IDB Group) An International VC fund with a vast partnership network, including companies such as: Siemens, Softbank, PCCW, Intel, Compaq etc.

Jonathan Gurfinkel

Director

Mr. Gurfinkel brings to the company accumulated management and technical experience in leading high-tech companies. Mr. Gurfinkel holds a Bachelor and M.Sc. in Electrical Engineering from Ben-Gurion University of the Negev, Beer-Sheba, Israel; and an EMBA from the Hebrew University of Jerusalem.

Prof. Nathan Keller, MD, Ph.D

Prof. Keller is head of clinical microbiology and a consultant on infectious diseases at the pediatric hemato-oncology department at Sheba Medical Center, Ramat Gan. He heads Israel’s national center for meningococcal disease, and is a member of Israel’s advisory committee for vaccines and infectious diseases. He serves on Sheba Medical Center’s animal ethical committee, as vice chairman of the hospital’s ethical review board, and as a member of Sheba’s formulary committee. He previously served as president of the Israeli Society for Infectious Diseases.

Prof. Keller is a member of the scientific advisory board at Pfizer Israel, MSD Israel, and Astella Israel. He is a scientific advisor to several Israeli biomed startups, including Pocared, Contipi, Elphitech, Eos, and other companies involved in developing microbiological diagnostics. Additionally, he is chairman of the advisory board at Anjon, USA, and a member of the advisory board at Safeguard Biosystems, USA

Having published over 147 manuscripts in peer-reviewed scientific journals, Prof. Keller’s main interests are diagnosis of infectious diseases, epidemiology of infectious diseases, epidemiology of antibiotic resistance, meningococcal disease, and fungal infections within pediatric hemato-oncology.

Prof. Keller is a graduate of Hadassah Medical School at the Hebrew University, Jerusalem, with a Ph.D in medical microbiology from the Royal University in Utrecht, and an MBA from Kellogg School of Management.

Prof. Rasmus Bro

Prof. Bro is a full professor at the University of Copenhagen’s Dept. of Food Science, and holds several teaching positions in a number of universities worldwide.

Prof. Bro has published 188 peer reviewed papers with an h-index of 66. His most cited paper has been cited more than two thousand times and is by far the most cited paper on the subject on Web of Science. The research in this paper has led to new scientific fields such as the use of fluorescence spectroscopy for monitoring dissolved organic matter in environmental analysis.

Prof. Bro holds an MSc in Analytical Chemistry from The Technical University of Denmark, and a PhD in Multi-way Analysis from University of Amsterdam.

Marie Castagno Pezzlo

Ms. Pezzlo is a consulting microbiologist with years of experience in her field. Throughout her career Marie has held editorial board positions on several Journals such as Journal of Clinical Microbiology and Laboratory Medicine.

Ms. Pezzlo has 50 publications include peer-reviewed publications, book chapters and books, and 44 abstracts.
Ms. Pezzlo holds a BA from the university of Connecticut and an MA in statistical analysis of in vitro antimicrobial susceptibility testing from St. Joseph college.

Janet A. (Fick) Hindler, M.Sc

Ms. Hindler is a senior specialist in clinical microbiology and is the R&D manager of the clinical microbiology laboratory at UCLA Medical. She is also a consultant to the association of public health laboratories.

Ms. Hindler has over 110 publications, and 80 book chapters and monographs and is considered a go to source of knowledge on antimicrobial susceptibility testing and CLSI, CDC and FDA issues.

Ms Hindler holds a B.Sc. in biology from Albright college and an MSc in clinical laboratory science from the university of California.